Millipore Sigma Vibrant Logo

236015 COX-2 Inhibitor V, FK3311 - CAS 116686-15-8 - Calbiochem

The COX-2 Inhibitor V, FK3311, also referenced under CAS 116686-15-8, controls the biological activity of COX-2. This small molecule/inhibitor is primarily used for Cell Signaling applications.

Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.

Sinónimos: 4ʹ-Acetyl-2ʹ-(2,4-Difluorophenoxy)methanesulfonanilide

View Products on Sigmaaldrich.com
236015
Ver precios y disponibilidad

Descripción

Replacement Information

Tabla espec. clave

CAS #Empirical Formula
116686-15-8C₁₅H₁₃F₂NO₄S

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
236015-5MG
Comprobando disponibilidad...
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      		 Frasco de vidrio 5 mg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      —
      Solicitar precio
      		 —
      Description
      OverviewA cell-permeable and orally available sulfonanilide that acts as a COX-2-selective non-steroidal anti-inflammatory drug (NSAID). Shown to exhibit 500-fold greater potency in inhibiting the LPS-induced (IC50 = 316 nM in human mononuclear cells) than the non-induced/constitutive (IC50 = 160 µM in human platelets) TxB2 production in vitro and effectively alleviate warm ischemia-reperfusion injury in the canine liver and rat lung in vivo.
      Catalogue Number236015
      Brand Family Calbiochem®
      Synonyms4ʹ-Acetyl-2ʹ-(2,4-Difluorophenoxy)methanesulfonanilide
      References
      ReferencesOtani, Y., et al. 2007. J. Invest. Surg. 20, 175.
      Sunose, Y., et al. 2001. Transplant Proc. 33, 862.
      Grossman, C.J., et al. 1995. Inflamm. Res. 44, 253.
      Nakamura, K., et al. 1993. Chem. Pharm. Bull. 41, 2050.
      Tsuji, K., et al. 1992. Chem. Pharm. Bull. 40, 2399.
      Product Information
      CAS number116686-15-8
      FormWhite solid
      Hill FormulaC₁₅H₁₃F₂NO₄S
      Chemical formulaC₁₅H₁₃F₂NO₄S
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥98% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      S PhraseS: 22-24/25-36/39

      Do not breathe dust.
      Avoid contact with skin and eyes.
      Wear suitable protective clothing and eye/face protection.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      236015-5MG 04055977217155

      Documentation

      Licencias necesarias

      Título
      CARTA DE USO GENERAL 2016
      PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD

      COX-2 Inhibitor V, FK3311 - CAS 116686-15-8 - Calbiochem Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      COX-2 Inhibitor V, FK3311 - CAS 116686-15-8 - Calbiochem Certificados de análisis

      CargoNúmero de lote
      236015

      Referencias bibliográficas

      Visión general referencias
      Otani, Y., et al. 2007. J. Invest. Surg. 20, 175.
      Sunose, Y., et al. 2001. Transplant Proc. 33, 862.
      Grossman, C.J., et al. 1995. Inflamm. Res. 44, 253.
      Nakamura, K., et al. 1993. Chem. Pharm. Bull. 41, 2050.
      Tsuji, K., et al. 1992. Chem. Pharm. Bull. 40, 2399.
      Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision18-March-2009 RFH
      Synonyms4ʹ-Acetyl-2ʹ-(2,4-Difluorophenoxy)methanesulfonanilide
      DescriptionA cell-permeable and orally available sulfonanilide that acts as a COX-2-selective non-steroidal anti-inflammatory drug (NSAID). Shown to exhibit 500-fold greater potency in inhibiting the LPS-induced (IC50 = 316 nM in human mononuclear cells) than the non-induced/constitutive (IC50 = 160 µM in human platelets) TxB2 production in vitro and effectively alleviate warm ischemia-reperfusion injury in the canine liver and rat lung in vivo.
      FormWhite solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number116686-15-8
      Chemical formulaC₁₅H₁₃F₂NO₄S
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityDMSO (30 mg/ml) or Ethanol (15 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Toxicity Standard Handling
      ReferencesOtani, Y., et al. 2007. J. Invest. Surg. 20, 175.
      Sunose, Y., et al. 2001. Transplant Proc. 33, 862.
      Grossman, C.J., et al. 1995. Inflamm. Res. 44, 253.
      Nakamura, K., et al. 1993. Chem. Pharm. Bull. 41, 2050.
      Tsuji, K., et al. 1992. Chem. Pharm. Bull. 40, 2399.